Lacosamide Injection
Product Images NDC 14445-406

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 14445-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Indoco Remedies Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig 1)

A bar chart illustrating the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose across three studies. The y-axis shows seizure reduction percentage from 0% to 45%. Each study compares placebo and two doses of Lacosamide, with higher doses generally showing greater seizure reduction. The chart highlights statistically significant differences versus placebo in some dose groups.*

FDA Label Image

Fig2 (Fig 2)

A line graph showing responder rate as a function of percent of patients for Lacosamide injection, including placebo and three daily dose levels (200 mg, 400 mg, and 600 mg). The vertical axis represents improvement or worsening, while the horizontal axis shows the percent of patients, illustrating comparative effectiveness among doses.*

FDA Label Image

Laco-inj-carton (Laco Inj Carton)

Packaging label for Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL) intravenous injection by Indoco Remedies Limited. The label includes prescription-only designation, NDC 14445-406-20, and states it contains a 20 mL single-dose vial of solution. It lists inactive ingredients and storage conditions, with a barcode and manufacturer address from Goa, India.*

FDA Label Image

Laco-inj-vial (Laco Inj Vial)

Label for Lacosamide Injection, USP, 200 mg/20 mL (10 mg/mL) single-dose vial for intravenous use. The label includes the NDC 14445-406-20, manufacturer Indoco Remedies Limited with address in Goa, India, storage instructions at 20-25°C, and a barcode. It also states the product is Rx only and provides usual dosage information guidance.*

FDA Label Image

Str (Str)

Chemical structure of Lacosamide, showing its molecular framework including a benzyl group, amide and ester functional groups consistent with the active ingredient in the Lacosamide injection product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.